125 related articles for article (PubMed ID: 19644817)
1. [Is intermittent peritoneal dialysis with icodextrin a valid option in the long-term treatment of refractory congestive heart failure?].
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
G Ital Nefrol; 2009; 26 Suppl 46():44-9. PubMed ID: 19644817
[TBL] [Abstract][Full Text] [Related]
2. Icodextrin and peritoneal dialysis: advantages and new applications.
Dousdampanis P; Musso CG; Trigka K
Int Urol Nephrol; 2018 Mar; 50(3):495-500. PubMed ID: 28674854
[TBL] [Abstract][Full Text] [Related]
3. Use of peritoneal ultrafiltration in the elderly refractory congestive heart failure patients.
Ruhi Ç; Koçak H; Yavuz A; Süleymanlar G; Ersoy FF
Int Urol Nephrol; 2012 Jun; 44(3):963-9. PubMed ID: 22388751
[TBL] [Abstract][Full Text] [Related]
4. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis.
Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
Nephrol Dial Transplant; 2012 May; 27(5):2044-50. PubMed ID: 21968011
[TBL] [Abstract][Full Text] [Related]
5. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.
Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S
Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589
[TBL] [Abstract][Full Text] [Related]
7. Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients.
Wang IK; Li YF; Chen JH; Liang CC; Liu YL; Lin HH; Chang CT; Tsai WC; Yen TH; Huang CC
Nephrology (Carlton); 2015 Mar; 20(3):161-7. PubMed ID: 25487756
[TBL] [Abstract][Full Text] [Related]
8. The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome.
Basile C; De Padova F; Montanaro A; Giordano R
J Nephrol; 2003; 16(3):384-6. PubMed ID: 12832738
[TBL] [Abstract][Full Text] [Related]
9. [Effect of using icodextrin as a starting therapy for peritoneal permeability].
Fernández-Reyes MJ; Bajo MA; del Peso G; Olea T; Sánchez-Villanueva RL; González E; Heras M; Sánchez R; Selgas R
Nefrologia; 2009; 29(2):130-5. PubMed ID: 19396318
[TBL] [Abstract][Full Text] [Related]
10. Novel peritoneal dialysis solutions--what are the clinical implications?
Jörres A
Blood Purif; 2012; 33(1-3):153-9. PubMed ID: 22269466
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
[TBL] [Abstract][Full Text] [Related]
12. Early quality of life benefits of icodextrin in peritoneal dialysis.
Guo A; Wolfson M; Holt R
Kidney Int Suppl; 2002 Oct; (81):S72-9. PubMed ID: 12230484
[TBL] [Abstract][Full Text] [Related]
13. Diuretic-resistant congestive heart failure treated successfully with peritoneal ultrafiltration.
Próchnicka A; Krzesiński P; Hałas K; Dziuk M; Niemczyk S; Wańkowicz Z
Kardiol Pol; 2013; 71(4):393-5. PubMed ID: 23788345
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with icodextrin. Multicenter study].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
[TBL] [Abstract][Full Text] [Related]
15. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
16. Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions.
Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
Am J Kidney Dis; 2009 Oct; 54(4):711-20. PubMed ID: 19619922
[TBL] [Abstract][Full Text] [Related]
17. Home peritoneal ultrafiltration in patients with severe congestive heart failure without end-stage renal disease.
Bertoli SV; Ciurlino D; Maccario M; Martino S; Bigatti G; Traversi L; Procaccio M; Buzzi L
Adv Perit Dial; 2005; 21():123-7. PubMed ID: 16686301
[TBL] [Abstract][Full Text] [Related]
18. An update on peritoneal dialysis solutions.
García-López E; Lindholm B; Davies S
Nat Rev Nephrol; 2012 Feb; 8(4):224-33. PubMed ID: 22349485
[TBL] [Abstract][Full Text] [Related]
19. A novel "bimodal" use of icodextrin peritoneal dialysis solutions.
Burkart J
Kidney Int; 1998 Apr; 53(4):1089-90. PubMed ID: 9551423
[No Abstract] [Full Text] [Related]
20. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
